公开(公告)号：US20220155305A1

公开(公告)日：2022-05-19

申请号：US17586870

申请日：2022-01-28

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Yifat MERBL ,  Aaron JAVITT ,  Assaf KACEN ,  Avital EISENBERG-LERNER ,  Merav SHMUELI

IPC: G01N33/574 ,  A61K39/395

Abstract: A method of treating lung cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent that downregulates an amount or activity of a polypeptide selected from the group consisting of CASC5, MYOF, CTNS, FCGR2B, PCDHGC5, POMGNT2, ACSL1, CTAGE5, TECPR2, WDR48, MCPH1, PPP2R3C, ADRB1, JAG2, GEMIN7, PTPRB, PRMT9, PSME4, Ube2L3, TP53RK and PSME3.